← Back to Search

Orthopedic Implant

Monoblock for Osteoarthritis

N/A
Waitlist Available
Research Sponsored by Zimmer Biomet
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This trial will compare the two types of tibia replacements in order to see which one performs better.

Eligible Conditions
  • Osteoarthritis
  • Joint Dislocation
  • Polyarthritis
  • Bow Legs or Knock Knees
  • Rheumatoid Arthritis
  • Osteonecrosis of the Femoral Condyle

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Radiographic Parameters
Secondary outcome measures
Oxford Knee Score
Revision Rate

Trial Design

2Treatment groups
Experimental Treatment
Group I: MonoblockExperimental Treatment1 Intervention
Subjects that receive the NexGen TM Monoblock Tibia
Group II: ModularExperimental Treatment1 Intervention
Subjects that receive the NexGen TM Modular Tibia
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
NexGen TM Monoblock Tibia
2017
N/A
~190
NexGen TM Modular Tibia
2017
N/A
~190

Find a Location

Who is running the clinical trial?

Zimmer BiometLead Sponsor
373 Previous Clinical Trials
67,213 Total Patients Enrolled
129 Trials studying Osteoarthritis
32,942 Patients Enrolled for Osteoarthritis
Kacy Arnold, RN, MBAStudy DirectorZimmer Biomet
15 Previous Clinical Trials
3,820 Total Patients Enrolled
11 Trials studying Osteoarthritis
2,969 Patients Enrolled for Osteoarthritis

Media Library

NexGen TM Modular Tibia (Orthopedic Implant) Clinical Trial Eligibility Overview. Trial Name: NCT03272373 — N/A
Osteoarthritis Research Study Groups: Monoblock, Modular
Osteoarthritis Clinical Trial 2023: NexGen TM Modular Tibia Highlights & Side Effects. Trial Name: NCT03272373 — N/A
NexGen TM Modular Tibia (Orthopedic Implant) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03272373 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any research centers in North America conducting this study?

"This clinical trial has 7 total sites available for patients to enroll. Three of these locations are University of Pennsylvania in Philadelphia, Henry County Orthopedics and Sports Medicine in New Castle, and Pinehurst Surgical Clinic in Pinehurst; the remaining four centres have yet to be disclosed."

Answered by AI

Is this research endeavor taking on new participants?

"According to clinicaltrials.gov, this trial has already concluded its recruitment and is not accepting new participants at the moment; it was initially posted on October 3rd 2017 with a final update in April 11th 2023. Nevertheless, there are 1036 other studies that currently require volunteers for their research protocol."

Answered by AI
~24 spots leftby Apr 2025